brain disease: A disease affecting the brain or part of the brain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
339 |
4. Check minimum number of eventsNone |
339 |
5. Include endpointsNone |
339 |
6. Filter based on genotype QC (FinnGen only) |
339 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G93
- Name in latin
- Encephalopathia non specificata
Similar endpoints
↥List of similar endpoints to
Encephalopathy
based on the number of shared cases.
Similar with more cases:
- Other neurological diseases
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4284 | 1649 | 2575 |
| Only index persons | 2826 | 1169 | 1657 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.05 | 0.07 |
| Only index persons | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 60.73 | 60.46 | 60.73 |
| Only index persons | 58.69 | 58.57 | 58.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 339 | 126 | 213 |
| Unadjusted period prevalence (%) | 0.07 | 0.04 | 0.09 |
| Median age at first event (years) | 59.71 | 56.29 | 61.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 308
- Matched controls
- 3078
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G93.4
ICD-10 Finland
Encephalopathy, unspecified
+∞
323.0
280
*
3483X
ICD-9 Finland
Other conditions of brain, Encephalopathy, unspecified
+∞
30.7
29
*
A07AA11
ATC
rifaximin; oral
320.6
29.3
29
*
AA1AD
NOMESCO Finland
CT of head and brain
4.5
28.0
122
390
A06AD11
ATC
lactulose; oral
5.1
27.8
102
272
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
20.7
26.9
40
22
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
21.1
26.4
39
21
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.9
22.7
54
81
R41.0
ICD-10 Finland
Disorientation, unspecified
13.0
22.5
40
35
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.5
21.5
136
571
R18
ICD-10 Finland
Ascites
17.4
21.1
33
21
K70.4
ICD-10 Finland
Alcoholic hepatic failure
118.0
20.8
22
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.1
19.2
85
262
K72.9
ICD-10 Finland
Hepatic failure, unspecified
106.6
18.8
20
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
23.5
18.5
26
12
R56.8
ICD-10 Finland
Other and unspecified convulsions
8.5
18.1
40
53
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.7
18.0
54
110
C03DA01
ATC
spironolactone; oral
4.4
17.6
69
188
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
27.4
17.2
23
9
C03CA01
ATC
furosemide; systemic
2.9
15.6
129
617
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
6.5
15.5
41
71
R53
ICD-10 Finland
Malaise and fatigue
3.3
15.1
89
338
A28
ICPC
Limited function/disability NOS
3.6
15.0
76
258
N03AX14
ATC
levetiracetam; systemic
11.3
14.5
27
26
N05AH04
ATC
quetiapine; oral
3.5
14.5
74
252
C07AA05
ATC
propranolol; systemic
3.5
14.3
76
266
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
13.7
68
226
K72.1
ICD-10 Finland
Chronic hepatic failure
42.0
13.3
16
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
10.8
13.2
25
25
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
13.2
63
202
N03AG01
ATC
valproic acid; systemic, rectal
5.6
13.2
39
78
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
33.6
12.7
16
5
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.9
12.5
42
97
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
10.7
12.2
23
23
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
12.1
103
486
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.1
12.0
38
82
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.2
12.0
22
21
XA800
NOMESCO Finland
Neuropsychological investigation
6.6
11.4
29
48
TAB00
NOMESCO Finland
Lumbar puncture
7.1
11.2
27
41
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.0
11.1
36
80
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.3
10.8
41
107
N05AD01
ATC
haloperidol; systemic
7.3
10.6
25
37
F05.9
ICD-10 Finland
Delirium, unspecified
9.3
10.5
21
24
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.8
10.5
45
132
R50.9
ICD-10 Finland
Fever, unspecified
3.1
10.3
59
216
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
9.6
10.2
20
22
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
17.4
10.0
15
9
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
4.2
10.0
38
100
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.4
9.9
36
90
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.6
9.9
34
81
N05AX08
ATC
risperidone; systemic
3.7
9.5
42
126
F10.09
ICD-10 Finland
Alcohol intoxication UNS
12.9
9.5
16
13
N05BA01
ATC
diazepam; systemic, rectal
3.1
9.5
54
197
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.2
9.4
36
95
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.3
9.4
48
162
P15
ICPC
Chronic alcohol abuse
8.1
9.3
20
26
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.6
9.3
23
37
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
14.3
9.3
15
11
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
9.2
38
108
N03AF02
ATC
oxcarbazepine; oral
6.9
9.1
22
34
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
37.9
9.1
11
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.9
9.1
29
64
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
9.1
67
286
N05AH03
ATC
olanzapine; systemic
4.8
8.9
29
65
103
Kela drug reimbursment
Diabetes, insulin-treated
2.3
8.8
102
553
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
8.8
41
129
SPAT1255
SPAT
Intravenous administration of medicine
4.2
8.8
33
86
J01MA02
ATC
ciprofloxacin; systemic
2.1
8.7
135
830
TK800
NOMESCO Finland
Hemodialysis
7.3
8.7
20
29
K92.1
ICD-10 Finland
Melaena
4.0
8.6
34
93
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.1
8.6
33
88
G41.9
ICD-10 Finland
Status epilepticus, unspecified
28.4
8.5
11
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
28.4
8.5
11
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
8.5
89
458
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
8.5
68
305
UJD02
NOMESCO Finland
Gastroscopy
4.7
8.5
28
64
B03BA03
ATC
hydroxocobalamin; parenteral
4.4
8.4
30
74
A10AE04
ATC
insulin glargine; parenteral
3.3
8.4
42
139
R1250
NOMESCO Finland
Evaluation of functional capability
9.9
8.4
16
17
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
8.3
91
476
N06AX11
ATC
mirtazapine; oral
2.2
8.2
105
592
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.3
8.2
24
48
SPAT1229
SPAT
Assessment of need for aid
3.5
8.1
37
115
R55
ICD-10 Finland
Syncope and collapse
3.0
8.0
46
168
N05CF01
ATC
zopiclone; oral
2.1
8.0
110
639
N03AF01
ATC
carbamazepine; oral, rectal
4.3
8.0
29
73
N03AX12
ATC
gabapentin; oral
2.7
7.9
56
233
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
7.9
46
170
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.5
7.8
36
112
SPAT1262
SPAT
Handing over of treatment supplies
2.5
7.7
67
310
F10.20
ICD-10 Finland
Alcohol dependence currently independent
8.4
7.7
16
20
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.1
7.6
42
147
K76.7
ICD-10 Finland
Hepatorenal syndrome
25.7
7.6
10
*
L28
ICPC
Limited function/disability (L)
2.5
7.6
64
292
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
7.6
142
928
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.3
7.6
22
44
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.8
7.4
30
84
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.1
7.4
41
146
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
7.3
61
279
G41.2
ICD-10 Finland
Complex partial status epilepticus
+∞
7.3
7
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
+∞
7.3
7
*
G93.8
ICD-10 Finland
Other specified disorders of brain
+∞
7.3
7
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
7.3
7
*
N06AB04
ATC
citalopram; systemic
2.3
7.3
74
374
N03AE01
ATC
clonazepam; systemic
4.3
7.3
26
65
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
7.3
57
250
N02AA05
ATC
oxycodone; systemic
2.5
7.2
58
260
K92.0
ICD-10 Finland
Haematemesis
6.9
7.2
17
26
W19
ICD-10 Finland
Unspecified fall
3.1
7.2
40
142
N05BA09
ATC
clobazam; oral
20.6
7.2
10
5
K90
ICPC
Stroke/cerebrovascular accident
7.3
7.1
16
23
N05BE01
ATC
buspirone; oral
6.6
7.0
17
27
A41.9
ICD-10 Finland
Sepsis, unspecified
4.6
7.0
23
53
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
7.0
59
272
N03AX16
ATC
pregabalin; oral
2.2
6.9
75
391
N05BA04
ATC
oxazepam; oral
2.2
6.8
82
444
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
23.1
6.7
9
*
R11
ICD-10 Finland
Nausea and vomiting
3.3
6.5
31
100
SPAT1254
SPAT
Administration of medicine
2.5
6.5
53
240
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
71.2
6.4
7
*
N05AN01
ATC
lithium; oral
8.4
6.4
13
16
WX730
NOMESCO Finland
Conventional respirator
8.4
6.4
13
16
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.5
6.4
21
49
N05CD07
ATC
temazepam; oral
2.5
6.4
52
234
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
11.3
6.3
11
10
T90.5
ICD-10 Finland
Sequelae of intracranial injury
11.3
6.3
11
10
D97
ICPC
Liver disease NOS
18.5
6.3
9
5
G93.99
ICD-10 Finland
Disorder of brain, unspecified
+∞
6.3
6
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
6.3
49
216
N06AG02
ATC
moclobemide; oral
4.4
6.3
21
50
N03AX09
ATC
lamotrigine; oral
4.9
6.2
19
41
Z02.7
ICD-10 Finland
Issue of medical certificate
3.7
6.2
25
71
N06AX16
ATC
venlafaxine; oral
2.7
6.1
42
170
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
12.9
6.1
10
8
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.0
6.0
18
38
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023183) Ammonium ion [Moles/volume] in Plasma
96
56
23.52
121.70
12.3
2.6
umol/l
54.5
32.1
6.21
84
49
(3020779) Urea [Moles/volume] in Serum or Plasma
93
222
5.39
38.38
15.7
7.6
mmol/l
11.9
10.3
1.20
88
210
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
44
47
10.61
37.94
1.3
1.4
e6/l
3.5
10.6
0.56
38
36
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
30
20
16.36
34.36
1.3
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
113
348
4.37
33.60
10.6
5.7
mmol/l
1.1
1.0
0.86
107
320
(3044290) Cell count panel - Cerebral spinal fluid
36
40
9.95
30.01
1.3
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
90
254
4.46
29.69
5.3
2.2
g/l
0.2
0.2
7.88
85
236
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
20
11
19.26
24.91
1.2
1.1
mmol/l
1.9
1.7
0.69
20
11
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
19
10
20.07
24.09
4.7
2.8
%
67.5
107.4
—
19
10
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
12
17.65
23.91
1.2
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
78
239
3.94
22.57
6.0
4.4
mmol/l
1.5
2.0
0.39
65
185
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
10
18.95
22.24
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
21
11.68
21.77
1.3
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
109
427
3.29
21.54
6.1
3.0
mmol/l
0.8
0.8
2.39
102
400
(3017143) Hepatitis C virus Ab [Presence] in Serum
79
261
3.64
20.34
1.9
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
15
13.36
19.59
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
23
25
9.80
19.31
2.4
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
23
10.16
18.97
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
17
12
14.86
18.61
5.2
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
44
7.11
18.61
1.2
1.1
u/ml
349.8
336.2
0.05
22
23
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
158
845
2.63
16.79
5.3
2.4
u/l
66.0
56.7
0.58
149
774
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
46
6.54
16.66
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
53
6.11
16.64
1.2
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
113
515
2.79
16.48
1.8
1.7
nmol/l
1250.6
1140.6
0.46
91
375
(3023368) Bacteria identified in Blood by Culture
148
781
2.59
15.99
7.9
4.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
65
5.33
15.32
1.2
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
79
308
3.04
15.23
3.3
4.1
u/l
230.8
259.2
1.13
71
291
(40768441) Liver Pathology biopsy report
19
22
9.09
15.15
2.6
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
75
286
3.08
15.01
1.9
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
20
9
23.51
14.39
3.9
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
11
13.23
14.34
4.0
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
204
1294
2.45
14.28
14.4
6.8
mmol/l
1.2
1.2
1.29
185
1079
(3024561) Albumin [Mass/volume] in Serum or Plasma
187
1148
2.40
14.00
14.7
4.9
g/l
31.9
35.4
10.82
178
1071
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
79
322
2.90
13.97
9.7
3.1
umol/l
18.5
8.4
0.84
70
285
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
28
7.53
13.69
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
72
4.80
13.62
1.5
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
75
302
2.90
13.53
11.1
7.6
mmol/l
1.0
1.2
0.09
61
240
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
53
5.45
13.39
2.5
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
72
286
2.93
13.30
2.6
1.7
%
1.8
1.5
1.74
63
244
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
55
188
3.30
13.13
2.5
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
28
58
5.17
13.09
8.0
8.1
iu/ml
2009.0
167.3
—
5
9
(3042733) HLA Ab [Presence] in Serum
17
6
29.71
13.08
2.2
7.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
76
314
2.83
13.04
1.7
1.4
titre
395.8
387.9
0.03
19
73
(3000991) Gas panel - Venous blood
60
220
3.10
12.73
11.8
9.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
22
8.08
12.39
1.1
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
95
450
2.54
12.38
2.5
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
77
329
2.73
12.35
1.9
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
78
4.43
12.34
5.0
2.3
u/ml
0.2
0.3
2.25
19
40
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
19
29
6.88
12.04
1.1
1.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
76
334
2.64
11.47
2.7
2.9
%
2.3
1.9
1.76
66
303
(3004789) Transferrin [Mass/volume] in Serum or Plasma
85
397
2.52
11.31
4.2
2.3
g/l
2.2
2.3
1.29
80
366
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
68
4.40
10.84
1.4
1.4
ug/g
320.0
287.2
0.34
16
34
(3032080) INR in Blood by Coagulation assay
172
1100
2.14
10.72
15.3
9.2
inr
1.2
1.3
0.52
42
304
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
80
372
2.51
10.69
4.3
2.4
%
22.1
22.0
0.02
65
321
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
23
7.25
10.66
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
167
3.11
10.46
1.4
1.5
—
—
—
0
0
(4281824)
17
27
6.58
10.37
1.4
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
15
8
19.54
10.35
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
18
8.07
10.21
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
21
7.43
10.21
1.4
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
10
11.34
10.21
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
120
677
2.20
10.20
3.1
2.0
mg/l
3.6
3.2
0.78
113
576
(3023520) Reticulocytes [#/volume] in Blood
59
243
2.73
10.04
2.2
2.8
e9/l
84.5
72.0
1.17
48
193
(3024471) HLA-A [Type]
15
9
17.35
9.96
1.0
1.0
—
—
—
0
0
(4027681)
13
16
8.41
9.80
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
50
192
2.88
9.69
8.1
3.9
mmol/l
2.3
1.9
0.26
37
139
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
11
10.30
9.59
1.3
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
11
10.30
9.59
1.2
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
179
1200
2.04
9.44
14.0
6.0
mmol/l
1.2
1.2
1.74
170
1076
(3026008) Bacteria identified in Urine by Culture
127
753
2.10
9.35
4.0
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
91
475
2.25
9.24
1.7
1.4
g/l
4.1
2.7
3.15
63
281
(3009343) pH of Capillary blood
51
204
2.77
9.15
8.1
3.8
ph
7.4
7.4
—
5
28
(3016018) Differential panel - Cerebral spinal fluid
13
18
7.47
8.90
1.1
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
65
4.07
8.86
3.6
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
215
1562
2.03
8.81
12.2
4.6
mmol/l
7.4
6.8
2.07
206
1467
(3019060) Gas panel - Arterial blood
47
187
2.76
8.51
8.3
4.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
65
307
2.38
8.26
2.4
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
20
6.72
8.12
1.1
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
5
22.66
8.06
1.3
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
313
2.33
7.89
2.4
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
156
1051
1.90
7.60
4.6
2.6
ug/l
150.9
151.7
0.02
148
957
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
45
4.41
7.57
2.0
3.1
u/ml
—
867.4
—
0
5
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
95
541
2.05
7.56
1.9
1.8
pmol/l
481.7
12809415.8
0.50
81
445
(3019198) Lymphocytes [#/volume] in Blood
182
1300
1.86
7.28
8.7
5.6
e9/l
1.7
1.9
1.16
173
1148
(3001604) Monocytes [#/volume] in Blood
179
1272
1.86
7.28
8.5
5.6
e9/l
0.6
0.6
0.54
172
1095
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
38
4.66
7.26
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
91
3.26
7.19
3.2
2.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
224
1715
1.90
7.14
7.1
4.2
e6/l
89.8
1235.1
—
8
27
(3022217) INR in Platelet poor plasma by Coagulation assay
72
377
2.16
7.10
16.0
26.0
inr
1.3
1.3
0.05
15
52
(3006315) Basophils [#/volume] in Blood
179
1279
1.85
7.09
8.8
5.6
e9/l
0.0
0.0
0.22
171
1103
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
35
4.75
7.00
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
75
406
2.09
6.77
3.8
2.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
51
237
2.36
6.67
1.9
1.8
nmol/l
501.6
384.9
0.41
51
213
(3020191) Ethanol [Moles/volume] in Serum or Plasma
12
21
5.89
6.63
1.9
1.4
promille
0.6
1.7
1.74
12
15
(3006653) Thiamine [Moles/volume] in Blood
11
9
12.58
6.62
1.0
1.1
nmol/l
135.9
137.7
—
11
9
(3013115) Eosinophils [#/volume] in Blood
182
1325
1.81
6.62
9.4
5.8
e9/l
0.2
0.2
1.01
175
1164
(3004588) Protein electrophoresis panel - Serum or Plasma
42
180
2.52
6.54
3.1
2.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
200
1503
1.81
6.49
13.7
9.4
e9/l
4.0
4.2
0.41
188
1308
(3015235) Bicarbonate [Moles/volume] in Capillary blood
25
81
3.25
6.46
5.9
2.8
mmol/l
24.3
25.0
0.23
20
70
(3021960) Folate [Moles/volume] in Serum or Plasma
102
625
1.90
6.45
1.8
1.6
nmol/l
19.8
20.1
0.07
92
520
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
7
14.67
6.43
1.3
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
132
879
1.82
6.41
9.0
5.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
146
1008
1.79
6.25
3.2
2.2
nmol/l
69.6
75.5
1.37
135
888
(3022096) Basophils/100 leukocytes in Blood
164
1172
1.77
6.23
9.0
5.8
%
0.7
0.6
0.22
159
1095
(3007853) Bacteria identified in Skin by Aerobe culture
62
323
2.13
6.15
2.1
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
53
3.74
6.13
1.8
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
8
12.83
6.12
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
8
12.83
6.12
1.3
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
142
982
1.77
5.98
4.7
3.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
156
2.54
5.96
1.6
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
36
4.31
5.88
1.5
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
91
552
1.89
5.87
3.3
2.7
e6/l
6.5
4.5
0.82
83
490
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
102
642
1.84
5.86
4.2
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
134
2.62
5.73
14.9
9.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
41
185
2.38
5.72
5.0
3.8
ng/l
117.7
92.2
0.51
36
159
(3018418) pH of Serum or Plasma
117
776
1.78
5.62
8.6
4.1
ph
7.4
7.4
0.05
20
153
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
7
13.16
5.61
1.3
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
7
13.16
5.61
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
21
67
3.28
5.57
9.1
3.2
ph
7.4
7.4
0.32
16
58
(3044640) Blood type and Crossmatch panel - Blood
123
833
1.75
5.46
4.3
2.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
164
1203
1.70
5.45
9.3
5.8
%
2.9
2.9
0.00
158
1120
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
79
3.05
5.41
1.5
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
8
11.51
5.32
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
124
847
1.73
5.32
4.0
3.1
mmol/l
6.9
7.9
1.74
112
699
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
226
2637
0.57
5.28
5.6
5.0
mmol/l
2.4
2.7
5.36
211
2394
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
217
2559
0.58
5.28
5.0
4.5
mmol/l
1.3
1.4
6.23
204
2330
(3002030) Lymphocytes/100 leukocytes in Blood
166
1234
1.68
5.16
9.5
6.0
%
25.6
27.2
1.00
161
1141
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
31
4.32
5.14
1.3
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
52
903
0.50
5.12
3.3
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
163
1209
1.67
5.09
7.1
4.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
220
2578
0.58
5.08
5.1
4.5
mmol/l
4.2
4.6
7.76
207
2372
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
148
1071
1.68
5.08
2.6
2.0
pmol/l
91.1
92.9
0.17
84
557
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
19
5.39
5.07
2.4
1.4
g/l
0.9
1.0
—
10
19
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
89
559
1.80
5.06
2.0
1.7
mg/l
2.3
1.4
0.76
73
437
(3022313) Gas panel - Capillary blood
34
150
2.41
4.99
9.2
3.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
222
1794
1.69
4.90
6.8
4.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
7
11.66
4.81
1.3
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
20
5.12
4.80
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
81
502
1.81
4.79
4.6
3.6
ng/l
321.9
369.6
0.06
67
403
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
30
128
2.47
4.73
10.0
4.4
mmol/l
24.5
24.7
0.09
30
118
(44790048)
12
29
4.25
4.66
1.7
1.8
—
—
—
0
0
(44790049)
12
29
4.25
4.66
1.7
1.8
—
—
—
0
0
(44806118)
12
29
4.25
4.66
1.7
1.8
—
—
—
0
0
(44790047)
12
29
4.25
4.66
1.7
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
64
3.09
4.63
7.4
3.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
11
8.37
4.59
6.3
5.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
54
3.26
4.55
1.9
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
54
3.26
4.55
1.9
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
50
3.31
4.39
1.8
1.6
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
34
160
2.25
4.33
15.5
9.4
%
93.6
94.1
0.17
34
160
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
56
3.14
4.30
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
6
11.87
4.29
1.3
1.0
miu/ml
1109.3
1425.0
—
7
6
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
6
11.87
4.29
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
103
2.54
4.24
2.5
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
27
116
2.44
4.21
1.6
2.1
u/l
39.6
38.8
0.06
22
103
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
79
504
1.74
4.20
1.4
1.3
u/ml
1.1
1.6
0.43
16
124
(40768797) Stomach Pathology biopsy report
60
353
1.85
4.17
1.3
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
10
23
4.45
4.11
1.7
1.0
mosm/kgh2o
284.6
284.1
—
10
15
(3002582) Erythrocytes [#/volume] in Urine
116
824
1.62
4.09
4.6
3.3
e6/l
80.6
153.2
0.38
97
641
(21494755) Public health laboratory ask at order entry panel
5
207
0.23
3.97
1.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
42
723
0.52
3.87
2.5
3.0
ug/l
0.5
0.8
7.06
28
494
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
102
2.46
3.84
1.8
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
102
2.46
3.84
1.8
2.5
g/l
6.9
7.3
0.49
15
78
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
102
2.46
3.84
1.8
2.5
g/l
3.8
3.8
0.03
15
74
(3037121) Protein [Mass/volume] in Urine
23
96
2.50
3.81
4.5
3.5
g/l
0.5
0.4
0.25
12
36
(3019832) Treponema pallidum Ab [Presence] in Serum
25
110
2.37
3.72
1.4
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
110
2.37
3.72
3.0
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
62
2.83
3.64
1.9
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
132
2.22
3.57
1.4
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
41
3.26
3.53
1.7
2.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
95
2.41
3.41
1.7
2.6
g/l
2.8
3.1
0.61
15
76
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
217
2480
0.65
3.37
4.5
4.0
mmol/l
1.4
1.3
0.49
201
2243
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
240
2064
1.56
3.37
19.8
7.5
u/l
97.8
80.3
4.49
231
1923
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
71
2.62
3.35
1.7
2.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
48
3.00
3.34
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
45
260
1.84
3.31
7.4
4.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
127
960
1.52
3.28
5.4
3.8
e6/l
104.4
138.5
0.22
102
688
(3037756) Immunofixation for Serum or Plasma
16
60
2.75
3.27
2.0
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
19
4.84
3.26
2.9
2.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
101
728
1.55
3.24
3.8
3.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
15
5.43
3.21
1.5
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
111
820
1.53
3.18
4.0
3.2
mg/l
111.4
303.2
0.78
84
544
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
67
2.62
3.18
1.8
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
39
219
1.88
3.14
6.6
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
91
645
1.56
3.13
10.4
6.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
104
761
1.53
3.10
4.0
3.1
e6/l
0.8
0.5
0.61
83
574
(3021901) Oxygen saturation in Capillary blood
16
62
2.66
3.09
5.8
2.7
—
—
—
0
0
(3026782) Osmolality of Urine
77
528
1.59
3.05
3.8
2.9
mosm/kgh2o
531.3
570.6
0.82
67
447
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
12
5.93
3.03
1.7
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
135
1047
1.48
3.03
6.3
3.8
ng/l
30.7
50.0
1.82
114
767
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
51
2.82
3.02
1.3
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
204
1716
1.47
3.01
10.4
3.2
u/l
96.5
50.6
4.11
195
1591
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
63
2.62
3.00
1.9
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
5
10.12
2.99
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
80
0.00
2.96
0.0
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
115
868
1.49
2.94
4.9
3.9
mg/mmol
18.3
10.1
0.76
94
569
(40760888) Immunoglobulin light chains.free panel - Serum
15
58
2.66
2.91
4.5
3.7
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
9
22
4.17
2.90
1.2
1.6
u/l
20.9
13.9
—
9
22
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
112
843
1.49
2.89
3.0
3.1
ng/l
1727.6
1487.3
0.27
98
714
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
13
5.47
2.88
1.1
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
13
5.47
2.88
1.1
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
77
2.41
2.87
1.5
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
20
90
2.30
2.86
2.2
2.9
g/l
1.2
0.7
0.30
15
79
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
18
4.52
2.81
1.0
1.4
—
—
—
0
0
(4062490)
9
23
3.99
2.79
1.7
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
23
3.99
2.79
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
19
85
2.31
2.76
1.6
1.2
u/ml
0.9
3.8
—
6
7
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
10
6.08
2.71
2.3
2.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
24
3.82
2.69
3.0
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
24
3.82
2.69
2.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
61
2.53
2.66
1.5
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
55
2.61
2.65
1.4
1.8
—
—
—
0
0
(3020891) Body temperature
21
100
2.17
2.65
9.9
3.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
78
554
1.53
2.63
6.3
3.9
kg/l
1.0
1.0
—
8
92
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
38
2.96
2.60
1.3
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
39
2.88
2.50
1.5
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
48
308
1.65
2.48
3.0
4.4
ug/l
22.7
47.2
0.38
40
258
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
45
2.73
2.47
1.3
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
112
866
1.44
2.46
5.6
3.4
mmol/l
2.3
2.3
1.08
97
756
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
30
168
1.86
2.46
1.8
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
12
5.07
2.41
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
12
5.07
2.41
1.2
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
50
327
1.62
2.40
1.9
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
202
1.76
2.32
4.4
2.6
ml/min/173m2
58.7
64.7
0.33
16
88
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
13
4.68
2.28
1.2
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
66
2.33
2.28
1.7
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
94
713
1.44
2.27
4.6
2.7
umol/l
16226.0
10141.2
0.28
85
603
(3051651) Icteric interference index of Serum or Plasma
7
18
3.95
2.26
4.1
3.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
198
0.39
2.25
1.3
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
75
996
0.68
2.23
3.5
4.4
%
17.5
21.6
1.74
33
495
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
36
2.83
2.22
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
20
3.55
2.06
1.3
1.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
7
20
3.55
2.06
2.9
2.0
e9/l
0.2
0.1
—
7
15
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
290
1.59
2.06
5.5
3.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
12
50
2.45
2.05
3.7
2.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
38
2.68
2.02
3.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
26
3.13
2.02
4.3
3.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
32
2.86
2.01
1.6
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
13
57
2.33
2.00
1.0
1.1
u/l
60.2
22.0
0.48
13
48
(3000093) Morphology [Interpretation] in Blood Narrative
7
21
3.38
1.97
1.6
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
21
3.38
1.97
2.9
2.0
e6/l
584.0
486.6
—
7
15
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
65
472
1.47
1.96
3.3
2.7
e6/l
2.6
0.9
0.97
44
279
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
211
1861
1.35
1.95
4.5
3.5
pmol/l
14.6
14.9
0.66
194
1653
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
16
3.80
1.94
1.3
2.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
39
2.61
1.94
2.1
1.7
—
—
—
0
0
(3015736) pH of Urine
118
955
1.36
1.92
5.1
3.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
218
1936
1.35
1.91
6.8
4.0
mm/h
19.4
12.7
5.05
205
1759
(3009542) Hematocrit [Volume Fraction] of Blood
215
2377
0.74
1.90
42.4
15.9
%
35.1
40.0
6.03
121
1646
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
22
3.23
1.89
1.6
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
86
2.03
1.88
1.7
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
28
2.90
1.87
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
46
2.44
1.87
4.8
3.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
35
2.61
1.81
1.2
1.9
pg
32.9
33.4
—
9
35
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
47
2.39
1.79
2.2
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
225
2462
0.74
1.77
35.2
13.8
ml/min/173m2
73.2
78.9
2.35
191
2030
(3011397) Hemoglobin [Presence] in Urine by Test strip
74
565
1.40
1.70
5.2
3.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
42
2.42
1.69
2.0
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
44
305
1.51
1.67
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
31
2.62
1.67
2.3
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
35
232
1.57
1.62
5.0
4.7
%
0.5
0.9
—
10
83
(3000963) Hemoglobin [Mass/volume] in Blood
276
2918
0.71
1.61
54.3
21.6
g/l
126.3
136.2
14.33
270
2865
(3010813) Leukocytes [#/volume] in Blood
276
2917
0.71
1.60
54.0
21.5
e9/l
6.9
6.8
0.34
270
2819
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
137
1.73
1.60
2.6
2.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
26
2.73
1.59
2.7
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
26
2.73
1.59
1.1
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
103
1242
0.75
1.59
3.3
5.0
ug/l
1.5
3.2
2.12
91
1102
(3026361) Erythrocytes [#/volume] in Blood
276
2916
0.71
1.58
53.8
21.5
e12/l
4.2
4.5
14.53
269
2816
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
16
85
1.93
1.57
1.7
1.4
iu/ml
0.0
0.1
—
5
20
(3006184) Hemoglobin [Mass/volume] in Capillary blood
13
64
2.07
1.56
4.6
2.4
g/l
131.9
129.3
0.10
13
49
(3044927) Protein electrophoresis panel - Urine
7
27
2.63
1.52
1.4
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
31
204
1.57
1.49
4.6
4.6
%
0.4
0.4
—
8
55
(36660697) Celiac disease serology panel - Serum
28
180
1.61
1.48
1.3
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
40
280
1.49
1.47
2.6
2.3
ug/g
143.1
121.9
0.24
34
233
(3023419) Bacteria identified in Sputum by Culture
9
38
2.41
1.46
1.3
3.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
38
2.41
1.46
2.1
3.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
445
1.39
1.46
4.3
2.9
e6/l
4.3
1.8
0.64
39
254
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
28
2.53
1.46
1.4
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
16
3.16
1.44
1.8
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
16
3.16
1.44
1.8
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
22
2.76
1.44
1.3
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
22
2.76
1.44
1.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
46
2.21
1.41
2.1
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
238
2558
0.77
1.41
5.7
4.7
mmol/l
6.6
6.0
4.92
222
2311
(3016879) Cocaine [Presence] in Urine
11
53
2.11
1.40
2.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
84
675
1.32
1.40
6.5
4.0
estimate
0.0
0.0
0.50
20
213
(40767503) Oxygen content in Capillary blood by calculation
12
60
2.04
1.40
7.3
2.7
%
16.8
16.3
—
7
35
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
23
2.64
1.37
1.2
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
5
17
2.97
1.36
1.6
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
17
2.97
1.36
1.2
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
42
2.17
1.34
4.6
2.9
mmol/l
105.8
105.5
—
9
42
(3041354) Potassium [Moles/volume] in Venous blood
9
42
2.17
1.34
4.6
2.9
mmol/l
4.3
4.1
—
9
42
(3019230) Fractional oxyhemoglobin in Venous blood
9
43
2.12
1.31
3.4
1.9
%
56.1
62.7
—
9
43
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
24
2.53
1.31
1.5
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
24
2.53
1.31
1.5
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
69
545
1.33
1.29
6.6
5.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
156
1.58
1.24
4.2
2.4
e9/l
4.3
4.2
0.02
18
116
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
37
2.19
1.22
2.6
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
56
712
0.74
1.22
2.0
1.7
mmol/l
1.6
1.4
0.73
48
590
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
64
505
1.33
1.21
3.9
3.0
mmol/l
2.5
2.5
1.58
52
443
(40761511) CBC panel - Blood by Automated count
257
2720
0.77
1.21
36.3
13.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
72
1.84
1.16
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
80
1.78
1.14
4.2
5.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
80
1.78
1.14
4.7
3.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
58
1.93
1.13
2.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
58
1.93
1.13
2.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
58
1.93
1.13
2.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
141
1238
1.24
1.13
5.4
3.7
estimate
0.0
0.0
0.00
23
225
(3042631) Mycobacterium sp identified in Specimen
8
40
2.02
1.13
1.8
3.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
41
1.97
1.09
5.0
2.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
59
1.89
1.08
2.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
33
2.14
1.06
1.7
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
34
2.08
1.03
2.0
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
29
206
1.45
1.03
4.7
4.9
%
0.0
0.2
—
10
63
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
232
2468
0.81
1.01
8.7
6.0
mmol/mol
42.2
40.3
1.48
220
2288
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
35
2.02
1.00
2.1
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
35
2.02
1.00
2.0
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
35
2.02
1.00
2.1
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
36
1.96
0.97
2.0
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
36
1.96
0.97
2.0
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
185
0.58
0.97
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
52
1.75
0.93
1.4
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
29
2.09
0.89
3.0
2.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
138
1233
1.20
0.89
6.6
5.1
estimate
0.0
0.0
0.00
23
227
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
128
1.51
0.88
1.2
1.2
iu/ml
39.1
135.5
—
10
48
(3023199) Leukocytes [#/volume] in Pleural fluid
6
30
2.02
0.87
1.2
1.3
e6/l
2002.8
1212.5
—
6
22
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
30
2.02
0.87
3.5
5.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
30
2.02
0.87
1.2
1.1
—
—
—
0
0
(4010399)
26
189
1.41
0.84
1.9
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
139
1253
1.19
0.80
5.3
3.7
estimate
0.0
0.0
0.00
21
210
(3003327) Ova and parasites identified in Stool by Light microscopy
12
75
1.62
0.76
1.7
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
109
967
1.19
0.75
6.2
3.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
24
2.10
0.75
1.4
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
24
2.10
0.75
5.6
2.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
25
2.01
0.73
1.0
1.3
u/l
11.8
11.0
—
5
25
(3021788) Differential panel - Synovial fluid
7
39
1.81
0.73
1.4
1.5
—
—
—
0
0
(4306422)
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
28
215
1.33
0.67
5.9
4.9
%
0.0
0.1
—
9
74
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
70
1.59
0.66
1.6
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
270
2795
0.83
0.65
23.5
10.5
u/l
28.7
26.5
0.98
263
2692
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
29
1.73
0.64
1.0
1.4
u/l
465.8
281.9
—
5
29
(4035726)
31
245
1.29
0.62
1.5
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(4146454)
5
30
1.68
0.61
2.6
2.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
30
1.68
0.61
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
253
0.74
0.60
1.7
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
35
1.73
0.58
1.2
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
54
1.49
0.57
1.1
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
38
1.59
0.54
1.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
38
1.59
0.54
1.3
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
174
1843
0.89
0.51
4.5
3.9
—
—
—
0
0
(3013512) EKG study
91
821
1.15
0.50
5.4
4.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
218
0.77
0.44
7.6
3.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
270
2622
1.15
0.43
40.5
14.6
mg/l
22.1
25.7
1.65
246
2080
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
4.3
—
255.0
—
0
15
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
18
0.00
0.40
0.0
1.9
—
3.6
—
0
18
(3022621) pH of Urine by Test strip
20
163
1.24
0.35
3.0
2.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
100
1.31
0.34
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
380
1.15
0.33
1.3
1.3
u/ml
33.1
14.0
0.36
17
134
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
45
400
1.14
0.32
1.2
1.3
iu/ml
72.5
40.2
0.46
13
130
(40768793) Breast Pathology biopsy report
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
7
54
1.30
0.30
1.1
1.4
miu/ml
—
283.0
—
0
20
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
163
0.79
0.30
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
116
0.77
0.28
2.3
2.6
—
—
—
0
0
(3000492) Spirometry study
26
225
1.17
0.27
1.6
1.5
—
—
—
0
0
(4094501)
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
84
0.71
0.24
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
343
1.12
0.23
8.7
7.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
41
1.22
0.22
4.8
2.8
e9/l
2.5
4.7
—
5
41
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.2
—
287.3
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
43
1.17
0.21
4.8
3.4
%
54.0
56.4
—
5
43
(3027456) Digoxin [Moles/volume] in Serum or Plasma
6
48
1.25
0.20
3.8
3.1
nmol/l
0.8
0.8
—
6
39
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
115
0.78
0.20
1.1
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
109
1136
0.94
0.18
23.0
9.7
e9/l
0.0
0.0
0.07
101
926
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
359
1.10
0.17
4.7
4.5
%
29.6
31.1
0.41
32
231
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
63
1.11
0.17
2.7
1.4
iu/l
15.8
21.8
—
7
51
(42529406) Shigella sp [Presence] in Stool by Culture
8
72
1.11
0.16
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
275
0.90
0.15
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
160
0.87
0.14
1.6
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
97
0.82
0.14
1.1
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
237
2334
1.05
0.13
5.4
4.2
mu/l
2.0
2.0
0.03
219
2081
(4034850)
10
85
1.18
0.12
11.5
8.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
71
685
1.05
0.10
4.7
3.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
47
1.06
0.09
1.2
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
105
1024
1.04
0.09
2.4
2.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
63
0.79
0.08
2.0
2.0
pmol/l
159.4
234.0
—
5
56
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
35
363
0.96
0.05
1.3
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
148
1468
1.01
0.02
3.1
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
68
688
0.99
0.01
1.6
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
143
0.98
0.00
1.7
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
135
0.96
0.00
3.4
4.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
125
1.04
0.00
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
34
336
1.01
0.00
1.2
1.3
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
174.6
—
0
5
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
59
1.02
0.00
1.2
1.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
110.8
—
0
6
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
84
0.95
0.00
1.1
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
4.4
—
119.6
—
0
8
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
72
0.97
0.00
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
72
0.97
0.00
1.1
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_ENCEPATH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ENCEPATH | 5.197 [4.2, 6.43] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.725 |
During the follow-up period (1.1.1998 — 31.12.2019), 510 out of 1064 females with G6_ENCEPATH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ENCEPATH | 4.951 [4.13, 5.93] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 805 out of 1493 males with G6_ENCEPATH died.
Mortality risk
Mortality risk for people of age
years, who have G6_ENCEPATH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.537% | 0.72% |
| 5 | 3.665% | 5.005% |
| 10 | 8.454% | 11.984% |
| 15 | 15.556% | 22.374% |
| 20 | 26.651% | 35.56% |
Relationships between endpoints
↥Index endpoint: G6_ENCEPATH – Encephalopathy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data